
    
      The subjects are randomized to 2 study groups. Group 1 receives standard chemotherapy
      prescribed by the cancer doctor (carboplatin and paclitaxel)with a possible choice to extend
      chemotherapy for up to an additional 12 months.

      Group 2 receives standard chemotherapy in the same manner as group 1. In addition, they
      receive 12 months of oral or IV nutritional supplements.
    
  